Predictors and diagnostic strategies for early-stage pancreatic ductal adenocarcinoma: A retrospective study

Hideyo Kimura, Takao Ohtsuka, Taketo Matsunaga, Yusuke Watanabe, Koji Tamura, Noboru Ideno, Teppei Aso, Tetsuyuki Miyazaki, Takashi Osoegawa, Shinichi Aishima, Yoshihiro Miyasaka, Junji Ueda, Yasuhiro Ushijima, Hisato Igarashi, Tetsuhide Ito, Shunichi Takahata, Yoshinao Oda, Kazuhiro Mizumoto, Masao Tanaka

研究成果: ジャーナルへの寄稿記事

8 引用 (Scopus)

抄録

Objectives: As a strategy to diagnose early-stage pancreatic ductal adenocarcinoma (PDAC) is urgently needed, we aimed to clarify characteristics of early-stage PDAC. Methods: We retrospectively reviewed medical records of 299 consecutive patientswho underwent R0 or R1 surgical resection for PDAC between 1994 and 2013 and compared clinical characteristics between patients with early-stage (stages 0-I by Japanese General Rules for Pancreatic Cancer) and advanced-stage (stages II-IV) disease. Diagnostic processes were also analyzed. Results: Twenty-four patients (8%) had early-stage PDAC (stage 0: 11; stage I: 13). Univariate and multivariate analyses showed that presence or history of intraductal papillary mucinous neoplasm (P < 0.01), history of pancreatitis (P < 0.01), and presence or history of extrapancreatic malignancies (P = 0.01) independently predicted detection of early-stage PDAC. Cytological examination during endoscopic retrograde pancreatography cytology was ~65% sensitive in preoperative diagnosis of early-stage PDAC, whereas other imaging modalitieswere only 29% to 38%sensitive; 9 of 24 early-stage PDACs were diagnosed by endoscopic retrograde pancreatography cytology alone. Conclusions: Endoscopic retrograde pancreatography cytology for patients with intraductal papillary mucinous neoplasm or pancreatitis may help diagnose early-stage PDAC. Surveillance of extrapancreatic malignancies might also provide opportunities to detect early-stage PDAC as a second malignancy.

元の言語英語
ページ(範囲)1148-1154
ページ数7
ジャーナルPancreas
44
発行部数7
DOI
出版物ステータス出版済み - 10 1 2015

Fingerprint

Adenocarcinoma
Retrospective Studies
Cell Biology
Pancreatitis
Neoplasms
Second Primary Neoplasms
Pancreatic Neoplasms
Medical Records
Multivariate Analysis

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

これを引用

Predictors and diagnostic strategies for early-stage pancreatic ductal adenocarcinoma : A retrospective study. / Kimura, Hideyo; Ohtsuka, Takao; Matsunaga, Taketo; Watanabe, Yusuke; Tamura, Koji; Ideno, Noboru; Aso, Teppei; Miyazaki, Tetsuyuki; Osoegawa, Takashi; Aishima, Shinichi; Miyasaka, Yoshihiro; Ueda, Junji; Ushijima, Yasuhiro; Igarashi, Hisato; Ito, Tetsuhide; Takahata, Shunichi; Oda, Yoshinao; Mizumoto, Kazuhiro; Tanaka, Masao.

:: Pancreas, 巻 44, 番号 7, 01.10.2015, p. 1148-1154.

研究成果: ジャーナルへの寄稿記事

Kimura, H, Ohtsuka, T, Matsunaga, T, Watanabe, Y, Tamura, K, Ideno, N, Aso, T, Miyazaki, T, Osoegawa, T, Aishima, S, Miyasaka, Y, Ueda, J, Ushijima, Y, Igarashi, H, Ito, T, Takahata, S, Oda, Y, Mizumoto, K & Tanaka, M 2015, 'Predictors and diagnostic strategies for early-stage pancreatic ductal adenocarcinoma: A retrospective study', Pancreas, 巻. 44, 番号 7, pp. 1148-1154. https://doi.org/10.1097/MPA.0000000000000393
Kimura, Hideyo ; Ohtsuka, Takao ; Matsunaga, Taketo ; Watanabe, Yusuke ; Tamura, Koji ; Ideno, Noboru ; Aso, Teppei ; Miyazaki, Tetsuyuki ; Osoegawa, Takashi ; Aishima, Shinichi ; Miyasaka, Yoshihiro ; Ueda, Junji ; Ushijima, Yasuhiro ; Igarashi, Hisato ; Ito, Tetsuhide ; Takahata, Shunichi ; Oda, Yoshinao ; Mizumoto, Kazuhiro ; Tanaka, Masao. / Predictors and diagnostic strategies for early-stage pancreatic ductal adenocarcinoma : A retrospective study. :: Pancreas. 2015 ; 巻 44, 番号 7. pp. 1148-1154.
@article{b9fb3030ac29413490893c40a9910093,
title = "Predictors and diagnostic strategies for early-stage pancreatic ductal adenocarcinoma: A retrospective study",
abstract = "Objectives: As a strategy to diagnose early-stage pancreatic ductal adenocarcinoma (PDAC) is urgently needed, we aimed to clarify characteristics of early-stage PDAC. Methods: We retrospectively reviewed medical records of 299 consecutive patientswho underwent R0 or R1 surgical resection for PDAC between 1994 and 2013 and compared clinical characteristics between patients with early-stage (stages 0-I by Japanese General Rules for Pancreatic Cancer) and advanced-stage (stages II-IV) disease. Diagnostic processes were also analyzed. Results: Twenty-four patients (8{\%}) had early-stage PDAC (stage 0: 11; stage I: 13). Univariate and multivariate analyses showed that presence or history of intraductal papillary mucinous neoplasm (P < 0.01), history of pancreatitis (P < 0.01), and presence or history of extrapancreatic malignancies (P = 0.01) independently predicted detection of early-stage PDAC. Cytological examination during endoscopic retrograde pancreatography cytology was ~65{\%} sensitive in preoperative diagnosis of early-stage PDAC, whereas other imaging modalitieswere only 29{\%} to 38{\%}sensitive; 9 of 24 early-stage PDACs were diagnosed by endoscopic retrograde pancreatography cytology alone. Conclusions: Endoscopic retrograde pancreatography cytology for patients with intraductal papillary mucinous neoplasm or pancreatitis may help diagnose early-stage PDAC. Surveillance of extrapancreatic malignancies might also provide opportunities to detect early-stage PDAC as a second malignancy.",
author = "Hideyo Kimura and Takao Ohtsuka and Taketo Matsunaga and Yusuke Watanabe and Koji Tamura and Noboru Ideno and Teppei Aso and Tetsuyuki Miyazaki and Takashi Osoegawa and Shinichi Aishima and Yoshihiro Miyasaka and Junji Ueda and Yasuhiro Ushijima and Hisato Igarashi and Tetsuhide Ito and Shunichi Takahata and Yoshinao Oda and Kazuhiro Mizumoto and Masao Tanaka",
year = "2015",
month = "10",
day = "1",
doi = "10.1097/MPA.0000000000000393",
language = "English",
volume = "44",
pages = "1148--1154",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Predictors and diagnostic strategies for early-stage pancreatic ductal adenocarcinoma

T2 - A retrospective study

AU - Kimura, Hideyo

AU - Ohtsuka, Takao

AU - Matsunaga, Taketo

AU - Watanabe, Yusuke

AU - Tamura, Koji

AU - Ideno, Noboru

AU - Aso, Teppei

AU - Miyazaki, Tetsuyuki

AU - Osoegawa, Takashi

AU - Aishima, Shinichi

AU - Miyasaka, Yoshihiro

AU - Ueda, Junji

AU - Ushijima, Yasuhiro

AU - Igarashi, Hisato

AU - Ito, Tetsuhide

AU - Takahata, Shunichi

AU - Oda, Yoshinao

AU - Mizumoto, Kazuhiro

AU - Tanaka, Masao

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Objectives: As a strategy to diagnose early-stage pancreatic ductal adenocarcinoma (PDAC) is urgently needed, we aimed to clarify characteristics of early-stage PDAC. Methods: We retrospectively reviewed medical records of 299 consecutive patientswho underwent R0 or R1 surgical resection for PDAC between 1994 and 2013 and compared clinical characteristics between patients with early-stage (stages 0-I by Japanese General Rules for Pancreatic Cancer) and advanced-stage (stages II-IV) disease. Diagnostic processes were also analyzed. Results: Twenty-four patients (8%) had early-stage PDAC (stage 0: 11; stage I: 13). Univariate and multivariate analyses showed that presence or history of intraductal papillary mucinous neoplasm (P < 0.01), history of pancreatitis (P < 0.01), and presence or history of extrapancreatic malignancies (P = 0.01) independently predicted detection of early-stage PDAC. Cytological examination during endoscopic retrograde pancreatography cytology was ~65% sensitive in preoperative diagnosis of early-stage PDAC, whereas other imaging modalitieswere only 29% to 38%sensitive; 9 of 24 early-stage PDACs were diagnosed by endoscopic retrograde pancreatography cytology alone. Conclusions: Endoscopic retrograde pancreatography cytology for patients with intraductal papillary mucinous neoplasm or pancreatitis may help diagnose early-stage PDAC. Surveillance of extrapancreatic malignancies might also provide opportunities to detect early-stage PDAC as a second malignancy.

AB - Objectives: As a strategy to diagnose early-stage pancreatic ductal adenocarcinoma (PDAC) is urgently needed, we aimed to clarify characteristics of early-stage PDAC. Methods: We retrospectively reviewed medical records of 299 consecutive patientswho underwent R0 or R1 surgical resection for PDAC between 1994 and 2013 and compared clinical characteristics between patients with early-stage (stages 0-I by Japanese General Rules for Pancreatic Cancer) and advanced-stage (stages II-IV) disease. Diagnostic processes were also analyzed. Results: Twenty-four patients (8%) had early-stage PDAC (stage 0: 11; stage I: 13). Univariate and multivariate analyses showed that presence or history of intraductal papillary mucinous neoplasm (P < 0.01), history of pancreatitis (P < 0.01), and presence or history of extrapancreatic malignancies (P = 0.01) independently predicted detection of early-stage PDAC. Cytological examination during endoscopic retrograde pancreatography cytology was ~65% sensitive in preoperative diagnosis of early-stage PDAC, whereas other imaging modalitieswere only 29% to 38%sensitive; 9 of 24 early-stage PDACs were diagnosed by endoscopic retrograde pancreatography cytology alone. Conclusions: Endoscopic retrograde pancreatography cytology for patients with intraductal papillary mucinous neoplasm or pancreatitis may help diagnose early-stage PDAC. Surveillance of extrapancreatic malignancies might also provide opportunities to detect early-stage PDAC as a second malignancy.

UR - http://www.scopus.com/inward/record.url?scp=84942054915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942054915&partnerID=8YFLogxK

U2 - 10.1097/MPA.0000000000000393

DO - 10.1097/MPA.0000000000000393

M3 - Article

C2 - 26284536

AN - SCOPUS:84942054915

VL - 44

SP - 1148

EP - 1154

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 7

ER -